{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:50:50Z","timestamp":1791229850442,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,5,7]],"date-time":"2011-05-07T00:00:00Z","timestamp":1304726400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s10549-011-1544-9","type":"journal-article","created":{"date-parts":[[2011,5,6]],"date-time":"2011-05-06T11:02:26Z","timestamp":1304679746000},"page":"87-95","source":"Crossref","is-referenced-by-count":37,"title":["Prevalence of BRCA1\/2 mutations in sporadic breast\/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing"],"prefix":"10.1007","volume":"132","author":[{"given":"Kim","family":"De Leeneer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilse","family":"Coene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brecht","family":"Crombez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Simkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudy","family":"Van den Broecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Bols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Stragier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilse","family":"Vanhoutte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"De Paepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Poppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Claes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,7]]},"reference":[{"issue":"5182","key":"1544_CR1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266(5182):66\u201371","journal-title":"Science"},{"issue":"6559","key":"1544_CR2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","volume":"378","author":"R Wooster","year":"1995","unstructured":"Wooster R et al (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378(6559):789\u2013792","journal-title":"Nature"},{"issue":"5181","key":"1544_CR3","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1126\/science.8091231","volume":"265","author":"R Wooster","year":"1994","unstructured":"Wooster R et al (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12\u201313. Science 265(5181):2088\u20132090","journal-title":"Science"},{"issue":"8","key":"1544_CR4","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/jmg.39.8.611","volume":"39","author":"ND Kauff","year":"2002","unstructured":"Kauff ND et al (2002) Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families. J Med Genet 39(8):611\u2013614","journal-title":"J Med Genet"},{"issue":"1","key":"1544_CR5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/ng0197-103","volume":"15","author":"SA Gayther","year":"1997","unstructured":"Gayther SA et al (1997) Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat Genet 15(1):103\u2013105","journal-title":"Nat Genet"},{"issue":"2","key":"1544_CR6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1086\/302503","volume":"65","author":"A Tesoriero","year":"1999","unstructured":"Tesoriero A et al (1999) De novo BRCA1 mutation in a patient with breast cancer and an inherited BRCA2 mutation. Am J Hum Genet 65(2):567\u2013569","journal-title":"Am J Hum Genet"},{"issue":"4","key":"1544_CR7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10689-009-9270-8","volume":"8","author":"E Edwards","year":"2009","unstructured":"Edwards E et al (2009) Identification of a de novo BRCA1 mutation in a woman with early onset bilateral breast cancer. Fam Cancer 8(4):479\u2013482","journal-title":"Fam Cancer"},{"issue":"1","key":"1544_CR8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10549-009-0494-y","volume":"121","author":"O Diez","year":"2010","unstructured":"Diez O et al (2010) A novel de novo BRCA2 mutation of paternal origin identified in a Spanish woman with early onset bilateral breast cancer. Breast Cancer Res Treat 121(1):221\u2013225","journal-title":"Breast Cancer Res Treat"},{"key":"1544_CR9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1471-2350-9-58","volume":"9","author":"TV Hansen","year":"2008","unstructured":"Hansen TV et al (2008) Novel de novo BRCA2 mutation in a patient with a family history of breast cancer. BMC Med Genet 9:58","journal-title":"BMC Med Genet"},{"issue":"5","key":"1544_CR10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1399-0004.2009.01246.x","volume":"76","author":"M Marshall","year":"2009","unstructured":"Marshall M, Solomon S, Lawrence Wickerham D (2009) Case report: de novo BRCA2 gene mutation in a 35-year-old woman with breast cancer. Clin Genet 76(5):427\u2013430","journal-title":"Clin Genet"},{"issue":"2","key":"1544_CR11","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/jmg.39.2.126","volume":"39","author":"M Robson","year":"2002","unstructured":"Robson M et al (2002) Unique de novo mutation of BRCA2 in a woman with early onset breast cancer. J Med Genet 39(2):126\u2013128","journal-title":"J Med Genet"},{"issue":"2","key":"1544_CR12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/jmg.38.2.102","volume":"38","author":"RB Luijt van der","year":"2001","unstructured":"van der Luijt RB et al (2001) De novo recurrent germline mutation of the BRCA2 gene in a patient with early onset breast cancer. J Med Genet 38(2):102\u2013105","journal-title":"J Med Genet"},{"issue":"3","key":"1544_CR13","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/(SICI)1098-1004(1999)13:3<256::AID-HUMU12>3.0.CO;2-M","volume":"13","author":"K Claes","year":"1999","unstructured":"Claes K et al (1999) Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6\/16 flemish families with breast and\/or ovarian cancer but not in 12 sporadic patients with early-onset disease. Mutations in brief no. 224. Online. Hum Mutat 13(3):256","journal-title":"Hum Mutat"},{"issue":"7","key":"1544_CR14","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/humu.20340","volume":"27","author":"AH Hout van der","year":"2006","unstructured":"van der Hout AH et al (2006) A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic setting. Hum Mutat 27(7):654\u2013666","journal-title":"Hum Mutat"},{"issue":"5","key":"1544_CR15","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2353\/jmoldx.2009.090032","volume":"11","author":"K Leeneer De","year":"2009","unstructured":"De Leeneer K et al (2009) Genotyping of frequent BRCA1\/2 SNPs with unlabeled probes: a supplement to HRMCA mutation scanning, allowing the strong reduction of sequencing burden. J Mol Diagn JMD 11(5):415\u2013419","journal-title":"J Mol Diagn JMD"},{"issue":"6","key":"1544_CR16","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1373\/clinchem.2007.098764","volume":"54","author":"K Leeneer De","year":"2008","unstructured":"De Leeneer K et al (2008) Rapid and sensitive detection of BRCA1\/2 mutations in a diagnostic setting: comparison of two high-resolution melting platforms. Clin Chem 54(6):982\u2013989","journal-title":"Clin Chem"},{"key":"1544_CR17","doi-asserted-by":"crossref","unstructured":"De Leeneer K et al (2011) Massive parallel amplicon sequencing of the breast cancer genes\u00a0BRCA1\u00a0and BRCA2: opportunities, challenges, and limitations. Hum Mutat 32(3):335\u2013344","DOI":"10.1002\/humu.21428"},{"issue":"6","key":"1544_CR18","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/humu.20980","volume":"30","author":"A Rohlin","year":"2009","unstructured":"Rohlin A et al (2009) Parallel sequencing used in detection of mosaic mutations: comparison with four diagnostic DNA screening techniques. Hum Mutat 30(6):1012\u20131020","journal-title":"Hum Mutat"},{"issue":"7","key":"1544_CR19","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nm1437","volume":"12","author":"RK Thomas","year":"2006","unstructured":"Thomas RK et al (2006) Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing. Nat Med 12(7):852\u2013855","journal-title":"Nat Med"},{"issue":"6","key":"1544_CR20","first-page":"1076","volume":"55","author":"KM Carlson","year":"1994","unstructured":"Carlson KM et al (1994) Parent-of-origin effects in multiple endocrine neoplasia type 2B. Am J Hum Genet 55(6):1076\u20131082","journal-title":"Am J Hum Genet"},{"issue":"1","key":"1544_CR21","first-page":"233","volume":"60","author":"I Schuffenecker","year":"1997","unstructured":"Schuffenecker I et al (1997) Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma, Le Groupe d\u2019Etude des Tumeurs a Calcitonine. Am J Hum Genet 60(1):233\u2013237","journal-title":"Am J Hum Genet"},{"issue":"3","key":"1544_CR22","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1086\/302831","volume":"66","author":"RL Glaser","year":"2000","unstructured":"Glaser RL et al (2000) Paternal origin of FGFR2 mutations in sporadic cases of Crouzon syndrome and Pfeiffer syndrome. Am J Hum Genet 66(3):768\u2013777","journal-title":"Am J Hum Genet"},{"issue":"6","key":"1544_CR23","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s004390050287","volume":"98","author":"C Lazaro","year":"1996","unstructured":"Lazaro C et al (1996) Sex differences in mutational rate and mutational mechanism in the NF1 gene in neurofibromatosis type 1 patients. Hum Genet 98(6):696\u2013699","journal-title":"Hum Genet"},{"issue":"1\u20133","key":"1544_CR24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1155\/1999\/241046","volume":"15","author":"K Claes","year":"1999","unstructured":"Claes K et al (1999) Mutation analysis of the BRCA1 and BRCA2 genes in the Belgian patient population and identification of a Belgian founder mutation BRCA1 IVS5\u00a0+\u00a03A\u00a0>\u00a0G. Dis Markers 15(1\u20133):69\u201373","journal-title":"Dis Markers"},{"issue":"6","key":"1544_CR25","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/sj.bjc.6601656","volume":"90","author":"K Claes","year":"2004","unstructured":"Claes K et al (2004) BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast\/ovarian cancer families. Br J Cancer 90(6):1244\u20131251","journal-title":"Br J Cancer"},{"issue":"5645","key":"1544_CR26","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","volume":"302","author":"MC King","year":"2003","unstructured":"King MC, Marks JH, Mandell JB (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302(5645):643\u2013646","journal-title":"Science"},{"issue":"9220","key":"1544_CR27","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(00)02347-3","volume":"355","author":"EJ Meijers-Heijboer","year":"2000","unstructured":"Meijers-Heijboer EJ et al (2000) Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet 355(9220):2015\u20132020","journal-title":"Lancet"},{"issue":"11","key":"1544_CR28","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/jnci\/91.11.943","volume":"91","author":"J Peto","year":"1999","unstructured":"Peto J et al (1999) Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91(11):943\u2013949","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"1544_CR29","first-page":"581","volume":"58","author":"M Ford","year":"1997","unstructured":"Ford M, Murdoch J (1997) The management of ovarian cancer. Br J Hosp Med 58(11):581\u2013583","journal-title":"Br J Hosp Med"},{"issue":"1","key":"1544_CR30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/ng0596-123","volume":"13","author":"FJ Couch","year":"1996","unstructured":"Couch FJ et al (1996) BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat Genet 13(1):123\u2013125","journal-title":"Nat Genet"},{"issue":"7","key":"1544_CR31","first-page":"1367","volume":"58","author":"K Haraldsson","year":"1998","unstructured":"Haraldsson K et al (1998) BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease. Cancer Res 58(7):1367\u20131371","journal-title":"Cancer Res"},{"issue":"16","key":"1544_CR32","first-page":"3663","volume":"56","author":"G Johannesdottir","year":"1996","unstructured":"Johannesdottir G et al (1996) High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients. Cancer Res 56(16):3663\u20133665","journal-title":"Cancer Res"},{"issue":"11","key":"1544_CR33","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/bjc.1997.574","volume":"76","author":"E Mavraki","year":"1997","unstructured":"Mavraki E et al (1997) Germline BRCA2 mutations in men with breast cancer. Br J Cancer 76(11):1428\u20131431","journal-title":"Br J Cancer"},{"issue":"5","key":"1544_CR34","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1593\/neo.04193","volume":"6","author":"K Syrjakoski","year":"2004","unstructured":"Syrjakoski K et al (2004) BRCA2 mutations in 154 Finnish male breast cancer patients. Neoplasia 6(5):541\u2013545","journal-title":"Neoplasia"},{"issue":"2","key":"1544_CR35","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.canlet.2004.11.001","volume":"224","author":"S Charef-Hamza","year":"2005","unstructured":"Charef-Hamza S et al (2005) Loss of heterozygosity at the BRCA1 locus in Tunisian women with sporadic breast cancer. Cancer Lett 224(2):185\u2013191","journal-title":"Cancer Lett"},{"issue":"4","key":"1544_CR36","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7150\/ijms.5.197","volume":"5","author":"N Uhrhammer","year":"2008","unstructured":"Uhrhammer N et al (2008) BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases. Int J Med Sci 5(4):197\u2013202","journal-title":"Int J Med Sci"},{"issue":"10","key":"1544_CR37","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1136\/jmg.37.10.792","volume":"37","author":"D Ellis","year":"2000","unstructured":"Ellis D et al (2000) Low prevalence of germline BRCA1 mutations in early onset breast cancer without a family history. J Med Genet 37(10):792\u2013794","journal-title":"J Med Genet"},{"issue":"27","key":"1544_CR38","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1200\/JCO.2010.28.0719","volume":"28","author":"JS Kwon","year":"2010","unstructured":"Kwon JS et al (2010) Expanding the criteria for BRCA mutation testing in breast cancer survivors. J Clin Oncol 28(27):4214\u20134220","journal-title":"J Clin Oncol"},{"issue":"4","key":"1544_CR39","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/bcr72","volume":"2","author":"L Ottini","year":"2000","unstructured":"Ottini L et al (2000) BRCA1 and BRCA2 mutations in central and southern Italian patients. Breast Cancer Res BCR 2(4):307\u2013310","journal-title":"Breast Cancer Res BCR"},{"issue":"3","key":"1544_CR40","doi-asserted-by":"crossref","first-page":"E1200-40","DOI":"10.1002\/humu.21202","volume":"31","author":"A Borg","year":"2010","unstructured":"Borg A (2010) Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study. Hum Mut 31(3):E1200-40","journal-title":"Hum Mut"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-011-1544-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-011-1544-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-011-1544-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T15:40:49Z","timestamp":1560181249000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-011-1544-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,7]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["1544"],"URL":"https:\/\/doi.org\/10.1007\/s10549-011-1544-9","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,7]]}}}